Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Rhubarb use in patients treated with Kampo medicines--a risk for gastric cancer?

Mantani N, Sekiya N, Sakai S, Kogure T, Shimada Y, Terasawa K.

Yakugaku Zasshi. 2002 Jun;122(6):403-5.

2.

A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines.

Mantani N, Kogure T, Sakai S, Kainuma M, Kasahara Y, Niizawa A, Shimada Y, Terasawa K.

Phytomedicine. 2002 Jul;9(5):373-6.

PMID:
12222654
3.

[Effects of perioperative administration of Rhubarb on acute inflammatory response in patients with gastric cancer].

Cai J, Xuan ZR, Wei YP, Yang HB, Wang H.

Zhong Xi Yi Jie He Xue Bao. 2005 May;3(3):195-8. Chinese.

4.

Kampo medicines as alternatives for treatment of migraine: six case studies.

Ishida K, Sato H.

Complement Ther Clin Pract. 2006 Nov;12(4):276-80. Epub 2006 Sep 28.

PMID:
17030300
5.

[Study toxicity-attenuating effect and dose-toxicity relationship of rhubarb by processing based on correspondence analysis].

Wang J, Ma Y, Jin C, Zhang P, Xiao X, Zhao Y, Xing X, Ren Y.

Zhongguo Zhong Yao Za Zhi. 2009 Oct;34(19):2498-502. Chinese.

PMID:
20067022
6.

[Identification of official rhubarb samples based on IR spectra and neural networks].

Tang YF, Zhang ZY, Fan GQ, Zhu HJ, Wang XY.

Guang Pu Xue Yu Guang Pu Fen Xi. 2005 May;25(5):715-8. Chinese.

PMID:
16128071
7.

[Methodological study on quality evaluation of rhubarb based on purgative bioassay].

Li HF, Wang JB, Qu Y, Jin C, Wang Q, Xiao XH, Li ZL.

Zhongguo Zhong Yao Za Zhi. 2008 Jun;33(11):1309-12. Chinese.

PMID:
18831215
8.

[Study on the selection of crude drugs of rhubarb dispensing granule].

Li M, Liu Y, Li LX, Sun P.

Zhong Yao Cai. 2006 Apr;29(4):381-3. Chinese.

PMID:
16913494
9.

[Rationality of commercial specification of rhubarb based on chemical analysis].

Wang J, Zhang X, Xiao X, Chu X, Zhou C, Jin C, Yan D.

Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(4):470-6. Chinese.

PMID:
20450046
10.

Toxicological considerations of Kampo medicines in clinical use.

Ikegami F, Fujii Y, Satoh T.

Toxicology. 2004 May 20;198(1-3):221-8. Review.

PMID:
15138045
11.
12.

[Combination use of kampo-medicines and drugs affecting intestinal bacterial flora].

Ishihara M, Homma M, Kuno E, Watanabe M, Kohda Y.

Yakugaku Zasshi. 2002 Sep;122(9):695-701. Japanese.

13.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
14.
15.

[Extra-weak chemiluminescence of drugs. X. Extra-weak chemiluminescence quenching component of rhubarb].

Sato H, Kurosaki Y, Hirayama H, Mizugaki M.

Yakugaku Zasshi. 1990 Jan;110(1):55-8. Japanese.

PMID:
2355309
16.
17.

[Novel exploration of cathartic pharmacology induced by rhubarb].

Li F, Wang SC, Wang X, Ren QY, Wang W, Shang GW, Zhang L, Zhang SH.

Zhongguo Zhong Yao Za Zhi. 2008 Feb;33(4):481-4. Review. Chinese.

PMID:
18533509
18.

In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes.

Takahashi K, Uejima E, Morisaki T, Takahashi K, Kurokawa N, Azuma J.

J Clin Pharm Ther. 2003 Aug;28(4):319-27.

PMID:
12911685
19.

NTP Toxicology and Carcinogenesis Studies of EMODIN (CAS NO. 518-82-1) Feed Studies in F344/N Rats and B6C3F1 Mice.

National Toxicology Program .

Natl Toxicol Program Tech Rep Ser. 2001 Jun;493:1-278.

20.

Supplemental Content

Support Center